CTNNBIP1 and breast cancer: Concerning the molecular functions of miR-1229-3p, Tan et al. revealed that miR-1229 was overexpressed in breast cancer, and miR-1229 inhibited the expression of GSK-3β, APC and ICAT, the vital negative regulators of the Wnt/β-catenin pathway26.